Pete Stibbs: Launching New VTE Management Webinar Series at Argon Medical
Pete Stibbs, Senior Vice President, Global Medical Affairs and Medical Director at Argon Medical Devices, shared Argon Medical Devices’s post on LinkedIn:
“I’m excited to share the launch of our new VTE Management Webinar Series at Argon Medical.
Continuous education is essential as the evidence surrounding venous thromboembolism continues to evolve.
From updated clinical guidelines and landmark trials to advances in mechanical thrombectomy and patient selection, our goal is to provide practical, evidence-based discussions that clinicians can apply directly to patient care.
I’m especially pleased that our inaugural session will feature Professor Stephen Black, whose expertise and contributions to venous disease have helped shape the field.
If you’re involved in the management of DVT, PE, or other venous disorders, I hope you’ll join us for what promises to be an outstanding discussion.
I look forward to seeing many colleagues, collaborators, and friends there.”
Argon Medical Devices shared a post on LinkedIn:
“VTE Treatment Is Evolving. Are You Keeping Up?
Join Professor Stephen Black and Argon Medical for the first episode of our new VTE Management Webinar Series: Next-Generation VTE Care – a comprehensive discussion on updated guidelines, intervention strategies, and clinical impact.
Together, we’ll explore:
- How evolving guidelines and landmark trial data are redefining VTE intervention
- Why early intervention matters for long-term outcomes and quality of life
- The technologies and evidence shaping the next generation of VTE treatment
- The value of mechanical thrombectomy in an increasingly outcomes and cost-focused healthcare environment
August 19 | 5:00 PM EDT (10:00 PM BST)
We hope you’ll join us for this conversation – register now to save your seat for Episode One of a series you won’t want to miss.
Click here to register.”
Stay updated with Hemostasis Today.
-
Aug 7, 2026, 15:59Nita Radhakrishnan։ New Evidence-Based Guidelines for Transfusion-Dependent Thalassemia
-
Aug 7, 2026, 15:54Seema Dawood: Why the Peripheral Blood Smear Still Matters in the Age of Automation?
-
Aug 7, 2026, 15:42Mohammed Elmourtada Abdulgayoom։ Caplacizumab-Enabled Treatment of iTTP Without Plasma Exchange
-
Aug 7, 2026, 15:40Renata Evertz: THUNDER Study Sets a New Benchmark in Stroke Thrombectomy
-
Aug 7, 2026, 15:23Ashley Brown: An Incredible Week at the Hemostasis GRC
-
Aug 7, 2026, 15:04Danique Steeghs: Developing a Chip-Sized ADAMTS13 Activity Assay for TTP Point-of-Care Testing
-
Aug 7, 2026, 15:02Mohd Laraib: The Importance of Multidisciplinary Collaboration in the Management of CAPS
-
Aug 7, 2026, 15:02Sip Wijchers: How PFA Technology Influences Hemolysis and Renal Safety
-
Aug 7, 2026, 14:49Ana Sachetto: Investigating TF-Positive Extracellular Vesicles and DIC in Sepsis